Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interviews, record review and a facility policy titled, Oxygen Therapy-Mask, Nasal Cannla & Nebulizers, the facility failed to ensure a nebulizer treatment mask was not out of the ZIPLOCK bag and a hair brush resting on top of the nebulizer for Resident Identifier (RI) #48.
This was observed on 1/6/20 and affected one of one sampled residents' observed for breathing treatments.
Findings Include:
A review of a facilitypolicy titled, Oxygen Therapy -Mask, Nasal Cannula & Nebulizer with no date revealed . nebulizer masks and/or pipes should be stored in a plastic bag .
RI #48 was admitted to the facility on [DATE]. Diagnoses included Rheumatoid myopathy with rheumatoid arthritis, COPD(Chronic Obstructive Pulmonary Disease), heart failure, and anxiety disorder.
A review of RI #48's Physician orders for January 2020 included the order for albuterol sulfate 0.63 milligrams(mg)/3 milliters solution via high flow nebulizer by mouth four times daily for COPD.
On 1/06/20 at 2:07 PM, during the initial tour of the facility RI #48 was observed in bed resting with eyes closed. RI #48 was receiving oxygen by nasal cannula. The surveyor observed the breathing treatment machine with the treatment mask attached to the machine. The mask was uncovered and a hair brush was lying on top of the nebulizer mask attached to machine but uncovered.
On 01/06/20 at 02:31 PM, an interview was conducted with Employee Identifier (EI) #4, Licensed Practical Nurse. EI #4 was asked, if RI # 48 received breathing treatments. EI #4 replied, yes, she was fixing to give one then. EI #4 was asked, how long had RI #48 been receiving breathing treatments. EI #4 replied, it had been since RI #48 was admitted to the facility. EI #4 was asked, what was the order for breathing treatment. EI #4 replied, albuterol 0.63 mg per 3 milliliters. EI #4 was asked, to tell the surveyor where the breathing treatment mask was. EI #4, replied, on the bedside table attached to nebulizer with the plastic bag lying on the table beside the machine. EI #4 was asked, what was the protocol on storing the breathing treatment masks between treatments. EI #4 replied, it should be covered. EI #4 was asked if the breathing treatment mask was covered. EI #4 replied, no. EI #4 was asked what was the potential harm in not covering the mask between treatments. EI #4 replied, it could get germs and hair in mask.
On 1/09/20 at 10:20 AM, an interview was conducted with EI #2, Director of Nursing. EI #2 was asked, what was the policy on storing the breathing treatment masks between treatments. EI #2 replied, inside a ziplock bag. EI #2 was asked, what was the potential harm in not covering the mask and having a resident's hair brush on the nebulizer between treatments. EI #2 replied, it could get contaminated by germs.
This was observed on 1/6/20 and affected one of one sampled residents' observed for breathing treatments.
Findings Include:
A review of a facilitypolicy titled, Oxygen Therapy -Mask, Nasal Cannula & Nebulizer with no date revealed . nebulizer masks and/or pipes should be stored in a plastic bag .
RI #48 was admitted to the facility on [DATE]. Diagnoses included Rheumatoid myopathy with rheumatoid arthritis, COPD(Chronic Obstructive Pulmonary Disease), heart failure, and anxiety disorder.
A review of RI #48's Physician orders for January 2020 included the order for albuterol sulfate 0.63 milligrams(mg)/3 milliters solution via high flow nebulizer by mouth four times daily for COPD.
On 1/06/20 at 2:07 PM, during the initial tour of the facility RI #48 was observed in bed resting with eyes closed. RI #48 was receiving oxygen by nasal cannula. The surveyor observed the breathing treatment machine with the treatment mask attached to the machine. The mask was uncovered and a hair brush was lying on top of the nebulizer mask attached to machine but uncovered.
On 01/06/20 at 02:31 PM, an interview was conducted with Employee Identifier (EI) #4, Licensed Practical Nurse. EI #4 was asked, if RI # 48 received breathing treatments. EI #4 replied, yes, she was fixing to give one then. EI #4 was asked, how long had RI #48 been receiving breathing treatments. EI #4 replied, it had been since RI #48 was admitted to the facility. EI #4 was asked, what was the order for breathing treatment. EI #4 replied, albuterol 0.63 mg per 3 milliliters. EI #4 was asked, to tell the surveyor where the breathing treatment mask was. EI #4, replied, on the bedside table attached to nebulizer with the plastic bag lying on the table beside the machine. EI #4 was asked, what was the protocol on storing the breathing treatment masks between treatments. EI #4 replied, it should be covered. EI #4 was asked if the breathing treatment mask was covered. EI #4 replied, no. EI #4 was asked what was the potential harm in not covering the mask between treatments. EI #4 replied, it could get germs and hair in mask.
On 1/09/20 at 10:20 AM, an interview was conducted with EI #2, Director of Nursing. EI #2 was asked, what was the policy on storing the breathing treatment masks between treatments. EI #2 replied, inside a ziplock bag. EI #2 was asked, what was the potential harm in not covering the mask and having a resident's hair brush on the nebulizer between treatments. EI #2 replied, it could get contaminated by germs.